Skip to main content
Fig. 2 | BMC Cancer

Fig. 2

From: Comparison between nab-paclitaxel and solvent-based taxanes as neoadjuvant therapy in breast cancer: a systematic review and meta-analysis

Fig. 2

Forest plot of the pathological complete response by different definitions for neoadjuvant nab-paclitaxel versus sb-taxanes in the treatment of breast cancer. Grey boxes demonstrate the effect size of each study, and their size is proportional to the weight given to each study. The whiskers bilateral to each grey box represent the 95% confidence interval (CI) of each study’s effect size. A fixed model was used for odds ratio (OR) calculation. *, sub-total OR when excluding Moebus 2018 [22]

Back to article page